160 related articles for article (PubMed ID: 15456490)
1. Severe factor XI deficiency caused by a Gly555 to Glu mutation (factor XI-Glu555): a cross-reactive material positive variant defective in factor IX activation.
Zivelin A; Ogawa T; Bulvik S; Landau M; Toomey JR; Lane J; Seligsohn U; Gailani D
J Thromb Haemost; 2004 Oct; 2(10):1782-9. PubMed ID: 15456490
[TBL] [Abstract][Full Text] [Related]
2. Analysis of the factor XI variant Arg184Gly suggests a structural basis for factor IX binding to factor XIa.
Geng Y; Verhamme IM; Sun MF; Bajaj SP; Emsley J; Gailani D
J Thromb Haemost; 2013 Jul; 11(7):1374-84. PubMed ID: 23617568
[TBL] [Abstract][Full Text] [Related]
3. A cross-reactive material positive variant of coagulation factor XI (FXIP520L) with a catalytic defect.
Gailani D; Schmidt A; Sun MF; Bolton-Maggs PH; Bajaj SP
J Thromb Haemost; 2007 Apr; 5(4):781-7. PubMed ID: 17229051
[TBL] [Abstract][Full Text] [Related]
4. Structural role of Gly(193) in serine proteases: investigations of a G555E (GLY193 in chymotrypsin) mutant of blood coagulation factor XI.
Schmidt AE; Ogawa T; Gailani D; Bajaj SP
J Biol Chem; 2004 Jul; 279(28):29485-92. PubMed ID: 15090552
[TBL] [Abstract][Full Text] [Related]
5. Factor XI promotes hemostasis in factor IX-deficient mice.
Mohammed BM; Cheng Q; Matafonov A; Monroe DM; Meijers JCM; Gailani D
J Thromb Haemost; 2018 Oct; 16(10):2044-2049. PubMed ID: 30007049
[TBL] [Abstract][Full Text] [Related]
6. Characterization of a heparin binding site on the heavy chain of factor XI.
Zhao M; Abdel-Razek T; Sun MF; Gailani D
J Biol Chem; 1998 Nov; 273(47):31153-9. PubMed ID: 9813019
[TBL] [Abstract][Full Text] [Related]
7. Hydrogen-deuterium exchange mass spectrometry highlights conformational changes induced by factor XI activation and binding of factor IX to factor XIa.
Bar Barroeta A; van Galen J; Stroo I; Marquart JA; Meijer AB; Meijers JCM
J Thromb Haemost; 2019 Dec; 17(12):2047-2055. PubMed ID: 31519061
[TBL] [Abstract][Full Text] [Related]
8. Plasma Kallikrein Contributes to Coagulation in the Absence of Factor XI by Activating Factor IX.
Visser M; van Oerle R; Ten Cate H; Laux V; Mackman N; Heitmeier S; Spronk HMH
Arterioscler Thromb Vasc Biol; 2020 Jan; 40(1):103-111. PubMed ID: 31766871
[TBL] [Abstract][Full Text] [Related]
9. A novel factor XI missense mutation (Val371Ile) in the activation loop is responsible for a case of mild type II factor XI deficiency.
Bozzao C; Rimoldi V; Asselta R; Landau M; Ghiotto R; Tenchini ML; De Cristofaro R; Castaman G; Duga S
FEBS J; 2007 Dec; 274(23):6128-38. PubMed ID: 17971173
[TBL] [Abstract][Full Text] [Related]
10. The mechanism underlying activation of factor IX by factor XIa.
Gailani D; Geng Y; Verhamme I; Sun MF; Bajaj SP; Messer A; Emsley J
Thromb Res; 2014 May; 133 Suppl 1(0 1):S48-51. PubMed ID: 24759143
[TBL] [Abstract][Full Text] [Related]
11. Factor XI anion-binding sites are required for productive interactions with polyphosphate.
Geng Y; Verhamme IM; Smith SA; Cheng Q; Sun M; Sheehan JP; Morrissey JH; Gailani D
J Thromb Haemost; 2013 Nov; 11(11):2020-8. PubMed ID: 24118982
[TBL] [Abstract][Full Text] [Related]
12. Factor XI contributes to thrombin generation in the absence of factor XII.
Kravtsov DV; Matafonov A; Tucker EI; Sun MF; Walsh PN; Gruber A; Gailani D
Blood; 2009 Jul; 114(2):452-8. PubMed ID: 19351955
[TBL] [Abstract][Full Text] [Related]
13. Naturally occurring human antibodies against two distinct functional domains in the heavy chain of FXI/FXIa.
De La Cadena RA; Baglia FA; Johnson CA; Wenk RE; Amernick R; Walsh PN; Colman RW
Blood; 1988 Nov; 72(5):1748-54. PubMed ID: 2460161
[TBL] [Abstract][Full Text] [Related]
14. The dimeric structure of factor XI and zymogen activation.
Geng Y; Verhamme IM; Smith SB; Sun MF; Matafonov A; Cheng Q; Smith SA; Morrissey JH; Gailani D
Blood; 2013 May; 121(19):3962-9. PubMed ID: 23515926
[TBL] [Abstract][Full Text] [Related]
15. Factor XI homodimer structure is essential for normal proteolytic activation by factor XIIa, thrombin, and factor XIa.
Wu W; Sinha D; Shikov S; Yip CK; Walz T; Billings PC; Lear JD; Walsh PN
J Biol Chem; 2008 Jul; 283(27):18655-64. PubMed ID: 18441012
[TBL] [Abstract][Full Text] [Related]
16. Functional role of residue 193 (chymotrypsin numbering) in serine proteases: influence of side chain length and beta-branching on the catalytic activity of blood coagulation factor XIa.
Schmidt AE; Sun MF; Ogawa T; Bajaj SP; Gailani D
Biochemistry; 2008 Feb; 47(5):1326-35. PubMed ID: 18186617
[TBL] [Abstract][Full Text] [Related]
17. Structure and function of factor XI.
Emsley J; McEwan PA; Gailani D
Blood; 2010 Apr; 115(13):2569-77. PubMed ID: 20110423
[TBL] [Abstract][Full Text] [Related]
18. Model for a factor IX activation complex on blood platelets: dimeric conformation of factor XIa is essential.
Gailani D; Ho D; Sun MF; Cheng Q; Walsh PN
Blood; 2001 May; 97(10):3117-22. PubMed ID: 11342438
[TBL] [Abstract][Full Text] [Related]
19. The evolution of factor XI and the kallikrein-kinin system.
Ponczek MB; Shamanaev A; LaPlace A; Dickeson SK; Srivastava P; Sun MF; Gruber A; Kastrup C; Emsley J; Gailani D
Blood Adv; 2020 Dec; 4(24):6135-6147. PubMed ID: 33351111
[TBL] [Abstract][Full Text] [Related]
20. Evidence for factor IX-independent roles for factor XIa in blood coagulation.
Matafonov A; Cheng Q; Geng Y; Verhamme IM; Umunakwe O; Tucker EI; Sun MF; Serebrov V; Gruber A; Gailani D
J Thromb Haemost; 2013 Dec; 11(12):2118-27. PubMed ID: 24152424
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
